- Home
- CPRX vs SIG Comparison
CPRX vs SIG Comparison
Compare CPRX & SIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | SIG |
|---|---|---|
| Founded | 2002 | 1950 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 2006 | 1997 |
Fundamental Metrics
Financial Performance| Metric | CPRX | SIG |
|---|---|---|
| Price | $29.20 | $87.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $35.00 | ★ $111.14 |
| AVG Volume (30 Days) | ★ 1.3M | 726.7K |
| Earning Date | 05-06-2026 | 06-02-2026 |
| Dividend Yield | N/A | ★ 1.58% |
| EPS Growth | 28.24 | ★ 974.07 |
| EPS | 1.68 | ★ 7.08 |
| Revenue | $119,072,803.00 | ★ $6,247,100,000.00 |
| Revenue This Year | $9.20 | $1.39 |
| Revenue Next Year | $10.51 | $1.71 |
| P/E Ratio | $16.29 | ★ $12.42 |
| Revenue Growth | ★ 16.39 | N/A |
| 52 Week Low | $19.05 | $56.52 |
| 52 Week High | $28.10 | $110.20 |
Technical Indicators
Market Signals| Indicator | CPRX | SIG |
|---|---|---|
| Relative Strength Index (RSI) | 74.05 | 43.73 |
| Support Level | $22.41 | $79.65 |
| Resistance Level | N/A | $95.10 |
| Average True Range (ATR) | 1.11 | 3.52 |
| MACD | 0.29 | -0.44 |
| Stochastic Oscillator | 57.37 | 12.14 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.